Kristopher L. Hanson - 25 Oct 2025 Form 3 Insider Report for MapLight Therapeutics, Inc. (MPLT)

Role
General Counsel
Signature
/s/ Kristopher L. Hanson
Issuer symbol
MPLT
Transactions as of
25 Oct 2025
Net transactions value
$0
Form type
3
Filing time
27 Oct 2025, 16:50:29 UTC
Previous filing
24 May 2022
Next filing
28 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hanson Kristopher General Counsel C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY /s/ Kristopher L. Hanson 27 Oct 2025 0001789970

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MPLT Voting Common Stock 182,761 25 Oct 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MPLT Stock Option (Right to Buy) 25 Oct 2025 Voting Common Stock 43,333 $9.92 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 182,761 Restricted Stock Units (RSUs). Of the RSUs, (i) as to 26,690 RSUs, 16,125 vested in connection with the Issuer's IPO and the remainder will vest in quarterly installments through July 1, 2027; (ii) as to 13,647 RSUs, 7,392 vested in connection with the Issuer's IPO and the remainder will vest in quarterly installments through October 1, 2027; (iii) as to 48,194 RSUs, 21,085 vested in connection with the Issuer's IPO and the remainder will vest in quarterly installments through January 1, 2028; and (iv) as to 94,230 RSUs, 14/48ths will vest on July 1, 2026 and the remainder will vest in 12 quarterly installments thereafter. With respect to all RSUs, vesting is subject to the Reporting Person's continued service through each vesting date.
F2 Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
F3 This stock option vests over a period of four years, with 1/4th of the shares underlying the option vested on the one-year anniversary of April 24, 2023, the vesting commencement date, and 1/48th of the shares underlying the option vesting on a monthly basis thereafter, subject to the Reporting Person's continued service through each vesting date.